Literature DB >> 16525184

Resectable brain metastases.

Michael A Vogelbaum1, John H Suh.   

Abstract

Brain metastases are the most common brain tumors seen in clinical practice, comprising well over half of all brain tumors. For many years, surgical resection of brain metastases was considered a form of palliative therapy only, but more recently it has been shown to have a more important role in extending survival in appropriately selected patients. Newer surgical techniques have helped to reduce the morbidity associated with tumor resection. Although randomized studies have demonstrated the need for postoperative whole-brain radiotherapy, there remains interest in the use of other surgical adjuncts to delay or eliminate the need for fractionated radiotherapy. The use of various treatment modalities, particularly image-guided surgery and stereotactic radiosurgery, allows clinicians who are focused on the treatment of brain metastases to achieve superior levels of tumor control within the brain. As a result, overall survival is much more dependent on the status of the patient's systemic disease.

Entities:  

Mesh:

Year:  2006        PMID: 16525184     DOI: 10.1200/JCO.2005.04.6235

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  31 in total

Review 1.  A review of image-guided radiotherapy.

Authors:  George T Y Chen; Gregory C Sharp; Shinichiro Mori
Journal:  Radiol Phys Technol       Date:  2008-12-16

2.  [Radiotherapy of singular brain metastases].

Authors:  Stefanie Windischbauer; Felix Sedlmayer
Journal:  Wien Med Wochenschr       Date:  2010-02

Review 3.  Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier.

Authors:  Ankit I Mehta; Adam M Brufsky; John H Sampson
Journal:  Cancer Treat Rev       Date:  2012-06-22       Impact factor: 12.111

Review 4.  Airway hydration and COPD.

Authors:  Arunava Ghosh; R C Boucher; Robert Tarran
Journal:  Cell Mol Life Sci       Date:  2015-06-12       Impact factor: 9.261

Review 5.  Radiation therapy for cutaneous melanoma.

Authors:  Christopher A Barker; Nancy Y Lee
Journal:  Dermatol Clin       Date:  2012-06-07       Impact factor: 3.478

Review 6.  Neurosurgical management of patients with brain metastasis.

Authors:  Mustafa Aziz Hatiboglu; Kerime Akdur; Raymond Sawaya
Journal:  Neurosurg Rev       Date:  2018-07-29       Impact factor: 3.042

7.  Progress in the biological understanding and management of breast cancer-associated central nervous system metastases.

Authors:  Shaheenah Dawood; Ana M Gonzalez-Angulo
Journal:  Oncologist       Date:  2013-06-05

Review 8.  Current advances in understanding and managing secondary brain metastasis.

Authors:  Radhika Dasararaju; Amitkumar Mehta
Journal:  CNS Oncol       Date:  2013-01

9.  Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases.

Authors:  Dirk Rades; Jan-Dirk Kueter; Dagmar Hornung; Theo Veninga; Patrick Hanssens; Steven E Schild; Juergen Dunst
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

10.  Modern treatment of cerebral metastases: Integrated Medical Learning(SM) at CNS 2007.

Authors:  Michael A Vogelbaum; Anthony L Asher; Douglas Kondziolka; Nicholas M Boulis; Nathan R Selden; Brian L Hoh; Fred G Barker
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.